iBio Inc (IBIO)

12:30 PM

An Overview of iBio Inc (NASDAQ: IBIO)’s Stock Performance and Outlook - Marketing Sentinel

12:30 PM

07:24 AM

Analytical Overview: TMC the metals company Inc (TMC)’s Ratios Tell a Financial Story - DWinneX

07:24 AM

07:24 AM

Financial Metrics Unveiled: CISO Global Inc (CISO)’s Key Ratios in the Spotlight - DWinneX

07:24 AM

Apr 25, 2025

iBio - The Pharma Letter

Apr 25, 2025

Apr 25, 2025

AstralBio - The Pharma Letter

Apr 25, 2025

Apr 24, 2025

iBio Inc (IBIO) expanding its growth trajectory ahead - Sete News

Apr 24, 2025

Apr 23, 2025

Monitoring iBio Inc (IBIO) after recent insider movements - knoxdaily.com

Apr 23, 2025

Apr 23, 2025

In the Green: iBio Inc (IBIO) Closes at 0.70, Up/Down -17.43 from Previous Day - DWinneX

Apr 23, 2025

Apr 22, 2025

Ibio Inc Enters Exclusive License Agreement With AstralBio - marketscreener.com

Apr 22, 2025

Apr 22, 2025

iBio Enters Licensing Agreement for Obesity Treatment - TipRanks

Apr 22, 2025

Apr 22, 2025

iBio Inc (IBIO) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Apr 22, 2025

Apr 22, 2025

Breaking down IBIO’s current quarter earnings estimates - uspostnews.com

Apr 22, 2025

Apr 22, 2025

iBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBio - Yahoo Finance

Apr 22, 2025

Apr 22, 2025

Porch Group Inc (PRCH) Stock: A Year of Stock Market Dynamics - investchronicle.com

Apr 22, 2025

Apr 16, 2025

iBio stock touches 52-week low at $1.03 amid market challenges By Investing.com - Investing.com South Africa

Apr 16, 2025

Apr 16, 2025

iBio stock touches 52-week low at $1.03 amid market challenges - Investing.com Australia

Apr 16, 2025

Apr 08, 2025

iBio Highlights Advancements in Obesity Antibody Programs - TipRanks

Apr 08, 2025

Apr 08, 2025

iBio Inc (NASDAQ: IBIO): Time To Buy Over The Next Few Months - Marketing Sentinel

Apr 08, 2025

Apr 07, 2025

iBio reports promising data on obesity treatment antibody By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

iBio reports promising data on obesity treatment antibody - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

iBio stock touches 52-week low at $1.42 amid market challenges - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

iBio stock touches 52-week low at $1.42 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

Where Do Analysts Think The iBio Inc (NASDAQ: IBIO) Is Going - stocksregister.com

Apr 07, 2025

Apr 07, 2025

iBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays Bearish - MSN

Apr 07, 2025

Apr 07, 2025

Ibio reports preclinical results for antibodies in cardiometabolic and obesity pipeline - BioWorld MedTech

Apr 07, 2025

Apr 07, 2025

Ibio IncOn Track For Regulatory Submission For Ibio-600 In Q1 2026 - MarketScreener

Apr 07, 2025

Apr 07, 2025

iBio Reveals Promising Study Results for IBIO-600 - TipRanks

Apr 07, 2025

Apr 07, 2025

iBio announces data from non-human primate PK study of IBIO-600 - TipRanks

Apr 07, 2025

Apr 07, 2025

Game-Changing Clinical Data: iBio's New Drug Combines Muscle Growth with Massive Weight Loss - Stock Titan

Apr 07, 2025

Apr 06, 2025

Senior Mining ExecutiveFrederic Mercier-Langevin to Join Patriot Battery Metals - The Globe and Mail

Apr 06, 2025

Apr 03, 2025

Hartford Insurance Group Inc.(The) [HIG] Officer makes an insider purchase of 1,144 shares worth 0.14 million. - knoxdaily.com

Apr 03, 2025

Apr 02, 2025

Galaxy Digital UK Secures FCA License, Expanding Derivatives Trading Capabilities in London - The Globe and Mail

Apr 02, 2025

Apr 01, 2025

iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Apr 01, 2025

Mar 31, 2025

20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey

Mar 31, 2025

Mar 28, 2025

FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World

Mar 28, 2025

Mar 21, 2025

iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World

Mar 21, 2025

Mar 19, 2025

iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World

Mar 19, 2025

Mar 12, 2025

Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World

Mar 12, 2025

Mar 04, 2025

IBIO Stock Price and Chart — NASDAQ:IBIO - TradingView

Mar 04, 2025

Mar 03, 2025

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Mar 03, 2025

Mar 03, 2025

$IBIO stock is up 12% today. Here's what we see in our data. - Nasdaq

Mar 03, 2025

Feb 28, 2025

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Feb 28, 2025

Feb 28, 2025

iBio Inc [IBIO] gain 106.12% so far this year. What now? - dbtnews.com

Feb 28, 2025

Feb 27, 2025

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 27, 2025

Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 - Investing.com

Feb 27, 2025

Feb 27, 2025

iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 26, 2025

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Feb 26, 2025

Feb 25, 2025

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Feb 25, 2025

Feb 24, 2025

iBio Inc. stock falls Monday, still outperforms market - MarketWatch

Feb 24, 2025

Feb 22, 2025

iBio, Inc. Advances in Therapeutics and Leadership - TipRanks

Feb 22, 2025

Feb 21, 2025

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Feb 21, 2025

Feb 20, 2025

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Feb 20, 2025

Feb 20, 2025

iBio to Begin Trading on the Nasdaq Stock Exchange - GlobeNewswire

Feb 20, 2025